Michael Jorrin, "Doc Gumshoe"

Author Bio

Michael Jorrin,
I have been a medical writer for about 25 years; before that I was a documentary film maker, and some of my films were about medical subjects. I am not a physician, but I have a pretty good scientific background. I wouldn’t dream of recommending any kind of treatment to anyone, and I cannot give medical advice. However, I understand the medical literature and the data and evidence behind it, and I have an inquiring and skeptical turn of mind. I scrutinize and question and, sometimes, challenge the positions of some of the established health-care organizations as well as the marketers of health information. Eternal vigilance is a small price to pay for health. — Michael Jorrin (aka DocGumshoe) Michael Jorrin is a paid contributor to Stock Gumshoe, he has agreed to our trading restrictions but he chooses his own topics and his words and opinions are his own.

Author Archives

  • Bulletins from the Cardiac Front

    [Ed note: Here is our latest piece from “Doc Gumshoe”, who is a medical writer (not a doctor) who shares his wisdom with us at Stock Gumshoe a couple times a month.  He does not typically write specifically about investments, but does write about publicly traded companies and their drugs, and has agreed to our trading […]

  • Antibiotic Resistance: What’s Happening?

    [ed. note: Michael Jorrin, who I call Doc Gumshoe, is a longtime medical writer (not a doctor) who writes for us about medicine and health a couple times a month. He has agreed to our trading and disclosure restrictions, but does not generally write directly about investment ideas. His ideas, thoughts and words are his […]

  • The Miracle Cures Keep Coming 

    [ed. note: Michael Jorrin, who I call Doc Gumshoe, is a longtime medical writer (not a doctor) who writes for us about medicine and health a couple times a month. He has agreed to our trading and disclosure restrictions, but does not generally write directly about investment ideas. His ideas, thoughts and words are his […]

  • End of Winter Miscellany

    [ed. note: Michael Jorrin, who I like to call Doc Gumshoe, is a longtime medical writer (not a doctor) who writes about non-financial health and medical issues for us a couple times a month (past submissions can be found on his author page here). Like all of our authors, he chooses his own topics and […]

  • Responses to Recent Comments

    [ed note: Michael Jorrin is longtime medical writer who has been sharing his thoughts with our readers as “Doc Gumshoe” for several years (he’s not a doctor, I gave him the name). He generally covers medical and health news and sometimes health promotions and hype, but he rarely opines about investments or specific stocks. All […]

  • Thanksgiving Leftovers and Short Takes

    [ed note: Michael Jorrin is longtime medical writer who has been sharing his thoughts with our readers as “Doc Gumshoe” for several years (he’s not a doctor, I gave him the name). He generally covers medical and health news and sometimes health promotions and hype, but he rarely opines about investments or specific stocks. All […]

  • Supplements and Drugs: the Feud Redux

    [ed note: Michael Jorrin is longtime medical writer who has been sharing his thoughts with our readers as “Doc Gumshoe” for several years (he’s not a doctor, I gave him the name). He generally covers medical and health news and sometimes health promotions and hype, but he rarely opines about investments or specific stocks. All […]

  • Yet More Miracle Cures From On High

    [ed note: Michael Jorrin, who I dubbed “Doc Gumshoe” years ago, is a longtime medical writer (not a doctor) who writes for us about health and medicine topics a couple times a month. He chooses his own topics, and his words and opinions are his own.] Travis lofted a couple of these over my transom […]

  • Two Flubs and a Big Question Mark

    [ed. note: Michael Jorrin, who I call “Doc Gumshoe,” writes for us a couple times a month on health and medical issues — he is a longtime medical writer (not a doctor), he chooses his own topics, and his past articles can be found here.] Flub Number One is the puncture of the “female Viagra” […]

  • Recent Author Comments

    On What's Dave Lashmet's "Biggest Ever Breakthrough for treating Alzheimer's Disease?"
    I discussed aducanumab & Biogen Idec back in 2015 after the Phase Ib trial results. What was particularly positive is that the clearing of the amyloid was linked with an improvement in cognition scores. But then another trial showed no efficacy at [...]
    On Examining the "One Device to End All Disease... And It Costs Less Than $50" ad from Radical Technology Profits
    These tiny electronic devices may be able to detect signs of lots of diseases, but preventing & ending those diseases is another matter. To that I say, fat chance! But that doesn't mean they won't make a lot of money. Good luck, best, Michael Jor[...]
    On Here We Go Again! Another Plot to Suppress Life-Saving Cures!
    I've written about Parkinsonism, but not for Doc Gumshoe - not sure my piece would work in this context. Good luck to your wife! I'll look at what I wrote previously & check whether it's still up to date. Best, MJ[...]
    On Here We Go Again! Another Plot to Suppress Life-Saving Cures!
    Thanks very much - I'll check into nattokinase. It fits with the Academy's "Kinase N4" moniker. Best to all, Michael Jorrin (aka Doc Gumshoe)[...]
    On Here We Go Again! Another Plot to Suppress Life-Saving Cures!
    Thank you Indimod for the clarification, I have worked with investigators who considered PLOS in cases where other journals turned them down. In the cases of the specific paper I cited, I doubt whether those investigators would have made other options [...]
    On Here We Go Again! Another Plot to Suppress Life-Saving Cures!
    PLOS ONE claims to be peer-reviewed. What this amounts to is that the editorial board reads the submission and might - just might! - consult an outside expert. They publish a huge number of papers per day; from what I have learned, nothing gets rejected[...]
    On Here We Go Again! Another Plot to Suppress Life-Saving Cures!
    I don't think you read my piece.[...]
    On Bulletins from the Cardiac Front
    For a discussion of the difference between absolute and relative risk, may I refer you to the Doc Gumshoe piece from 2014 entitled "HRT: From Panacea to Anathema (and Back?). I noted that the difference in absolute and relative risks in the Women's Healt[...]
    On Bulletins from the Cardiac Front
    The TKR was for my left knee, the right knee having been swapped two years ago. The right knee epic was described in detail in a blog on May 1st, 2015, which you could find in the archive. With my left knee, I was in residential rehab for about a week [...]
    On Bulletins from the Cardiac Front
    The high-sensitivity cardiac troponin test (TnT) is indeed more sensitive than CK-MB, which is the creatine kinase subtype that indicates heart damage. The new improved TnT test may not be yet available in the US. Neither CK-MB nor the TnT test can rel[...]
    On Antibiotic Resistance: What’s Happening?
    "Lugol's iodine" is a very dilute solution of potassium iodide and iodine crystals. It has limited medical uses. At higher concentrations, iodine is destructive to our tissues. Yes, it is a disinfectant - it will kill all manner of microbes on contac[...]
    On Antibiotic Resistance: What’s Happening?
    Thanks, Marc - I'll do some sleuthing.[...]
    On The Miracle Cures Keep Coming 
    I discussed laetrile in some detail in a piece entitled "Supplements and Drugs: the Feud Redux," which posted on October 3, 2016. My short take is that there's not much to it. More to the point, if there were some clinical activity in those apricot pit[...]
    On End of Winter Miscellany
    Metformin's potential for increasing life-span was discussed at considerable length in a Doc Gumshoe piece on aging back in August 2015. The short take is that a cohort of people with diabetes treated with metformin had lower over-all mortality rates tha[...]
    On End of Winter Miscellany
    As in "The devil may care, but I don't care." My OED says, "The exclamation 'devil may care" used as an attribute: wildly reckless, careless and rolicking." A citation from Dickens, Pickwick Papers (1837): "He was a mighty free-and-easy, roving, devil-[...]
    On End of Winter Miscellany
    Controlling T2DM by means of diet and exercise may work for some individuals. I have a good friend whose T2DM was well-controlled by those means for several years, but eventually his A1c started to rise again and he had to resort to drug treatment. Mor[...]
    On Mampilly's "Untapped Ocean of Energy Found Under All 50 States"
    Here's to ten times ten more Gumshoe years! And that goes for Jen and the Gummie Sneakers as well![...]
    On Lichtenfeld's Alzheimer's Disease "Genius Molecule Discovery"
    AbbVie is an excellent, well-managed company with first-class research capabilities. I wouldn't dream of saying anything negative about an investment in their stock; over time AbbVie will surely do well since they have several current drugs that are effe[...]
    On Is Inflammation Really the Archvillain?
    Don't know much about anatabine, other than what I've learned on-line which you likely know already. A study that reported benefit consisted of an on-line survey of a couple of hundred people who were already anatabine users; most said it helped. Compa[...]
    On Is Inflammation Really the Archvillain?
    If using Voltaren or some other topical analgesic means you can reduce or omit the oral NSAID, that would "mitigate" the impact. But it depends on what you're treating. If you have RA, quelling the symptom does not stop the progress of the disease, whi[...]

    This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.